FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308348483> ?p ?o ?g. }

• W4308348483 endingPage "121.e10" @default.
• W4308348483 startingPage "121.e1" @default.
• W4308348483 abstract "This study was conducted to investigate risk factors and predictors of infectious and noninfectious pulmonary complications (PCs) after allogeneic hematopoietic stem cell transplantation in children. We conducted a retrospective analysis of the post-transplantation PCs of 240 patients who underwent allogeneic peripheral blood stem cell transplantation (allo-PBSCT) between 2009 and 2018. Transplantation-related variables, pretransplantation baseline spirometry, body plethysmography, and CO diffusing capacity were analyzed for association with the development of infectious PCs (IPCs) and noninfectious PCs (NIPCs). Compared with the control group, the PC group had statistically significantly lower overall survival (50.6% versus 77.8%; P < .001), higher disease-related mortality (26.6% versus 54.4%; P < .001), and higher nonrelapse mortality (31.6% versus 5.9%; P < .001). A greater number of patients received pretransplantation conditioning with high-dose busulfan (520 mg/m2; Bu 520) and fludarabine (160 mg/m2; Flu 160) in both the IPC and NIPC groups. In the multivariate Cox hazard regression analysis, Bu 520 significantly increased the risk of NIPCs (hazard ratio [HR], 1.99; 95% confidence interval [CI], 1.13 to 3.49; P = .016), and Flu 160 was a predictor of IPCs (HR, 1.99; 95% CI, 1.13 to 3.49; P = .016). The Bu 520 + Flu 160 regimen was associated with a statistically significant increase in the risk of NIPC (HR, 1.92; 95% CI, 1.09 to 3.37; P = .023). In a multivariate analysis using pretransplantation baseline lung function, alveolar volume (VA) grades 3 and 4 and lung function score (LFS) VA categories III and IV were associated with increased risk for both IPCs and NIPCs. Our data identify receipt of the high-dose Bu-Flu conditioning regimen as an independent risk factor for NIPCs after allo-PBSCT. Impaired CO diffusing capacity before transplantation, especially VA reduction, contributes to the risk of post-transplantation pulmonary complications, and pretransplantation risk can be estimated by grading the degree of insufficiency of VA and LFS VA." @default.
• W4308348483 created "2022-11-11" @default.
• W4308348483 creator A5002232086 @default.
• W4308348483 creator A5014044521 @default.
• W4308348483 creator A5025154088 @default.
• W4308348483 creator A5038837842 @default.
• W4308348483 creator A5055187245 @default.
• W4308348483 date "2023-02-01" @default.
• W4308348483 modified "2023-09-30" @default.
• W4308348483 title "High-Dose Busulfan-Fludarabine Conditioning and Low Alveolar Volume as Predictors of Pulmonary Complications after Allogeneic Peripheral Blood Stem Cell Transplantation in Children" @default.
• W4308348483 cites W2007519620 @default.
• W4308348483 cites W2011196154 @default.
• W4308348483 cites W2013883780 @default.
• W4308348483 cites W2032072100 @default.
• W4308348483 cites W2036353024 @default.
• W4308348483 cites W2041836775 @default.
• W4308348483 cites W2052865051 @default.
• W4308348483 cites W2054530824 @default.
• W4308348483 cites W2061694819 @default.
• W4308348483 cites W2066655678 @default.
• W4308348483 cites W2070132007 @default.
• W4308348483 cites W2088973049 @default.
• W4308348483 cites W2093744059 @default.
• W4308348483 cites W2099449365 @default.
• W4308348483 cites W2100665992 @default.
• W4308348483 cites W2107365801 @default.
• W4308348483 cites W2107925558 @default.
• W4308348483 cites W2112476822 @default.
• W4308348483 cites W2120734552 @default.
• W4308348483 cites W2127086092 @default.
• W4308348483 cites W2138359066 @default.
• W4308348483 cites W2153769722 @default.
• W4308348483 cites W2163605464 @default.
• W4308348483 cites W2610154296 @default.
• W4308348483 cites W2755145368 @default.
• W4308348483 cites W2756287961 @default.
• W4308348483 cites W2885865830 @default.
• W4308348483 cites W2915776957 @default.
• W4308348483 cites W2919650437 @default.
• W4308348483 cites W2951548798 @default.
• W4308348483 cites W3003957667 @default.
• W4308348483 cites W3025872076 @default.
• W4308348483 cites W3037740096 @default.
• W4308348483 cites W3093233637 @default.
• W4308348483 cites W3150370607 @default.
• W4308348483 cites W4220774279 @default.
• W4308348483 cites W4238264910 @default.
• W4308348483 doi "https://doi.org/10.1016/j.jtct.2022.10.024" @default.
• W4308348483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36336257" @default.
• W4308348483 hasPublicationYear "2023" @default.
• W4308348483 type Work @default.
• W4308348483 citedByCount "0" @default.
• W4308348483 crossrefType "journal-article" @default.
• W4308348483 hasAuthorship W4308348483A5002232086 @default.
• W4308348483 hasAuthorship W4308348483A5014044521 @default.
• W4308348483 hasAuthorship W4308348483A5025154088 @default.
• W4308348483 hasAuthorship W4308348483A5038837842 @default.
• W4308348483 hasAuthorship W4308348483A5055187245 @default.
• W4308348483 hasConcept C126322002 @default.
• W4308348483 hasConcept C141071460 @default.
• W4308348483 hasConcept C207103383 @default.
• W4308348483 hasConcept C2776042228 @default.
• W4308348483 hasConcept C2776694085 @default.
• W4308348483 hasConcept C2776755627 @default.
• W4308348483 hasConcept C2777408962 @default.
• W4308348483 hasConcept C2779263901 @default.
• W4308348483 hasConcept C2780333948 @default.
• W4308348483 hasConcept C2780611847 @default.
• W4308348483 hasConcept C2911091166 @default.
• W4308348483 hasConcept C44249647 @default.
• W4308348483 hasConcept C50382708 @default.
• W4308348483 hasConcept C71924100 @default.
• W4308348483 hasConcept C75603125 @default.
• W4308348483 hasConcept C90924648 @default.
• W4308348483 hasConceptScore W4308348483C126322002 @default.
• W4308348483 hasConceptScore W4308348483C141071460 @default.
• W4308348483 hasConceptScore W4308348483C207103383 @default.
• W4308348483 hasConceptScore W4308348483C2776042228 @default.
• W4308348483 hasConceptScore W4308348483C2776694085 @default.
• W4308348483 hasConceptScore W4308348483C2776755627 @default.
• W4308348483 hasConceptScore W4308348483C2777408962 @default.
• W4308348483 hasConceptScore W4308348483C2779263901 @default.
• W4308348483 hasConceptScore W4308348483C2780333948 @default.
• W4308348483 hasConceptScore W4308348483C2780611847 @default.
• W4308348483 hasConceptScore W4308348483C2911091166 @default.
• W4308348483 hasConceptScore W4308348483C44249647 @default.
• W4308348483 hasConceptScore W4308348483C50382708 @default.
• W4308348483 hasConceptScore W4308348483C71924100 @default.
• W4308348483 hasConceptScore W4308348483C75603125 @default.
• W4308348483 hasConceptScore W4308348483C90924648 @default.
• W4308348483 hasFunder F4320321379 @default.
• W4308348483 hasIssue "2" @default.
• W4308348483 hasLocation W43083484831 @default.
• W4308348483 hasLocation W43083484832 @default.
• W4308348483 hasOpenAccess W4308348483 @default.
• W4308348483 hasPrimaryLocation W43083484831 @default.
• W4308348483 hasRelatedWork W146568283 @default.
• W4308348483 hasRelatedWork W2133235702 @default.

• next